GlassScriptPhysician profile
Kunj G Patel
NPI 1699185249
$17,430.35
in general payments reported to CMS, 2019-2025
18 companies · $142 in 2025
The $142 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,645 · 2020: $5,133 · 2021: $1,231 · 2022: $1,808 · 2023: $2,018 · 2024: $1,454 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,356 · Travel and Lodging: $1,257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,356.47 |
| Travel and Lodging | $1,256.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elite Orthopedics, LLC | $4,031.21 | 2019-2021 | |
| Abbott Laboratories | $3,257.70 | 2019-2023 | Ensite Precision |
| Boston Scientific Corporation | $2,329.23 | 2019-2024 | Lux-Dx Insertable Cardiac Monitor |
| Medtronic, INC. | $1,703.37 | 2022-2023 | Selectsecure, Na, Micra |
| Medtronic USA, INC. | $1,546.46 | 2019-2020 | |
| Evolution Surgical, INC | $1,026.64 | 2024 | |
| Medtronic Vascular, INC. | $848.44 | 2019 | |
| Vertos Medical, INC. | $710.55 | 2019-2020 | |
| Stimwave Technologies Incorporated | $426.06 | 2019-2021 | |
| Arthrex, INC. | $391.68 | 2020-2024 | |
| Pacira Pharmaceuticals Incorporated | $267.00 | 2020 | |
| Curonix LLC | $239.71 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Genzyme Corporation | $185.00 | 2019 | |
| Flowonix Medical Incorporated | $147.50 | 2019 | |
| Atricure, INC. | $117.37 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertiflex, INC. | $81.71 | 2019 | |
| Nevro Corp. | $80.33 | 2019 | |
| Biosense Webster, INC. | $40.39 | 2023 | Carto 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kunj Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.